2012
Clinical Aspects of Blastocystis Infections: Advancements Amidst Controversies
Mirza H, Tan K. Clinical Aspects of Blastocystis Infections: Advancements Amidst Controversies. Parasitology Research Monographs 2012, 4: 65-84. DOI: 10.1007/978-3-642-32738-4_5.Commentaries, Editorials and LettersBlastocystis infectionParasite subtypeClinical presentationLuminal parasitesChronic abdominal discomfortIrritable bowel syndromeTreatment of choiceNovel treatment optionsDiverse clinical presentationsHuman stool samplesAbdominal discomfortBowel syndromeAcute diarrheaTreatment failureAsymptomatic carriageClinical manifestationsTreatment optionsCancer patientsImmunocompromised populationsClinical managementClassical diagnostic techniquesStool samplesTreatment outcomesClinical aspectsAnimal contact
2010
A Rapid, High-Throughput Viability Assay for Blastocystis spp. Reveals Metronidazole Resistance and Extensive Subtype-Dependent Variations in Drug Susceptibilities
Mirza H, Teo JD, Upcroft J, Tan KS. A Rapid, High-Throughput Viability Assay for Blastocystis spp. Reveals Metronidazole Resistance and Extensive Subtype-Dependent Variations in Drug Susceptibilities. Antimicrobial Agents And Chemotherapy 2010, 55: 637-648. PMID: 21098237, PMCID: PMC3028762, DOI: 10.1128/aac.00900-10.Peer-Reviewed Original ResearchConceptsTreatment failureBlastocystis infectionBlastocystis sppNew treatment optionsDrug-resistant isolatesStandard therapyTreatment regimensTreatment optionsMetronidazole resistanceControversial pathogenesisSubtype 4Drug susceptibilityImportant subtypeDrug sensitivitySubtypesStandard antimicrobialsInfectionZoonotic subtypesViability assaysPresent studyParasitesFirst studyCotrimoxazoleRegimensFailure